TITLE

Drug-Metabolizing Enzymes Mechanisms and Functions

AUTHOR(S)
Sheweita, Salah A.
PUB. DATE
September 2000
SOURCE
Current Drug Metabolism;Sep2000, Vol. 1 Issue 2, p107
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Drug-metabolizing enzymes are called mixed-function oxidase or monooxygenase and containing many enzymes including cytochrome P450, cytochrome b5 , and NADPH-cytochrome P450 reductase and other components. The hepatic cytochrome P450s (Cyp) are a multigene family of enzymes that play a critical role in the metabolism of many drugs and xenobiotics with each cytochrome isozyme responding differently to exogenous chemicals in terms of its induction and inhibition. For example, Cyp 1A1 is particularly active towards polycyclic aromatic hydrocarbons (PAHs), activating them into reactive intermediates those covalently bind to DNA, a key event in the initiation of carcinogenesis. Likewise, Cyp 1A2 activates a variety of bladder carcinogens, such as aromatic amines and amides. Also, some forms of cytochrome P450 isozymes such as Cyp 3A and 2E1 activate the naturally occurring carcinogens (e.g. aflatoxin B1 ) and N-nitrosamines respectively into highly mutagenic and carcinogenic agents. The carcinogenic potency of PAHs, and other carcinogens and the extent of binding of their ultimate metabolites to DNA and proteins are correlated with the induction of cytochrome P450 isozymes. Phase II drug-metabolizing enzymes such as glutathione S-transferase, aryl sulfatase and UDP-glucuronyl transferase inactivate chemical carcinogens into less toxic or inactive metabolites. Many drugs change the rate of activation or detoxification of carcinogens by changing the activities of phases I and II drug-metabolizing enzymes. The balance of detoxification and activation reactions depends on the chemical structure of the agents, and is subjected to many variables that are a function of this structure, or genetic background, sex, endocrine status, age, diet, and the presence of other chemicals. It is important to realize that the enzymes involved in carcinogen metabolism are also involved in the metabolism of a variety of substrates, and thus the introduction of specific xenobiotics may change the operating level and the existence of other chemicals. The mechanisms of modification of drug-metabolizing enzyme activities and their role in the activation and detoxification of xenobiotics and carcinogens have been discussed in the text.
ACCESSION #
11129779

 

Related Articles

  • Induction of Drug Metabolising Enzymes. Fuhr, Uwe // Clinical Pharmacokinetics;2000, Vol. 38 Issue 6, p493 

    Currently, 5 different main mechanisms of induction are distinguished for drug-metabolising enzymes. The ethanol type of induction is mediated by ligand stabilisation of the enzyme, but the others appear to be mediated by intracellular 'receptors'. These are the aryl hydrocarbon (Ah) receptor,...

  • Drug Metabolism and Increasing Age.  // British Medical Journal;6/14/1975, Vol. 2 Issue 5971, p581 

    Examines the activity of drug metabolizing enzymes on human in Great Britain. Change in the degree of binding of drugs by plasma proteins; Availability of the drug for metabolism and excretion; Medical implications for drug dosage.

  • Drug Metabolism and Individualized Medicine. Srivastava, Pratima // Current Drug Metabolism;Feb2003, Vol. 4 Issue 1, p33 

    Drug metabolism refers to the biochemical transformation of a compound into another more polar chemical form. Absorption, distribution, metabolism and excretion comprise an integral part in understanding the safety and efficacy of a potential new drug. Detailed in-depth knowledge of the...

  • Tumoral Drug Metabolism: Perspectives and Therapeutic Implications. M.M. Doherty; M. Michael // Current Drug Metabolism;Apr2003, Vol. 4 Issue 2, p131 

    Drug metabolising enzymes (DME) in tumors are capable of biotransforming a variety of xenobiotics. Over a long period of time, many studies have reported the presence of DME in tumors, however quantitation and sampling techniques and heterogeneous patient populations have resulted in many...

  • Species Differences in the Distribution of Drug-Metabolizing Enzymes in the Pancreas. Ulrich, Alexis B.; Standop, Jens; Schmied, Bruno M.; Schneider, Matthias B.; Lawson, Terence A.; Pour, Parviz M. // Toxicologic Pathology;Mar/Apr2002, Vol. 30 Issue 2, p247 

    We investigated the cellular expression of 9 cytochrome P450-isozymes (CYP1A1, CYP1A2, CYP2B6, CYP2C8,9,19, CYP2D1, CYP2E1, CYP3A1, CYP3A2, CYP3A4) and 3 glutathione S-transferase-isozymes (GST-π, GST-α, GST-μ) in the pancreas of hamsters, mice, rats, rabbits, pigs, dogs and monkeys,...

  • Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes. Wataru Habano; Kohei Kawamura; Natsuki Iizuka; Terashima, Jun; Tamotsu Sugai; Shogo Ozawa // Clinical Epigenetics;9/29/2015, Vol. 7 Issue 1, p1 

    Background: Drug metabolizing enzymes (DMEs) exhibit dramatic inter- and intra-individual variability in expression and activity. However, the mechanisms determining this variability have not been fully elucidated. The aim of this study was to evaluate the biological significance of DNA...

  • Technetium-99m DTPA inhalation scintigraphy in patients treated with fluoxetine and maprotiline: preliminary results. Capa Kaya, Gamze; Durak, Hatice; Yemez, Beyazit; Turhal, Ümit; Özdogan, Özhan; Sayit, Elvan; Degirmenci, Berna; Derebek, Erkan // European Journal of Nuclear Medicine;2000, Vol. 27 Issue 9, p1402 

    Abstract. Drug-metabolising enzymatic activities have been detected in tracheobronchiolar, bronchiolar and alveolar regions in the lungs. Induction of phospholipidosis by amine drugs such as clorphentermine has also been shown. This study aimed to investigate the effect of fluoxetine and...

  • Pharmacokinetics: phase one metabolism. Greene, Russell // Practice Nurse;9/24/2004 Prescribing Nurse, Vol. 28, p6 

    Discusses the concepts of the pharmacokinetic process. Information on how hydrophilic drugs may be cleared from the body; Function of the liver enzyme system in drug metabolism; Factors affecting drug kinetics.

  • Kidney CYP450 Enzymes: Biological Actions Beyond Drug Metabolism. Zhao, X.; Imig, J.D. // Current Drug Metabolism;Feb2003, Vol. 4 Issue 1, p73 

    Arachidonic acid can be metabolized by cytochrome P450 (CYP450) enzymes to 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids (EETs), their corresponding dihydroxyeicosatrienoic acids (DHETs), and 20-hydroxyeicosatetraenoic acid (20-HETE). These arachidonic acid metabolites are involved in...

Share

Read the Article

Other Topics